Howard I. Scher, MD, FASCO

Company: Memorial Sloan Kettering Cancer Center

Job title: Head, Biomarker Development Program Attending Physician Department of Medicine

Seminars:

10.40 | 7.40 – Expertise Panelist Discussion: The Additive Role of CTCs & ctDNA in Your Clinical Development Strategy 10:40 am

Complementing your biomarker evaluation with CTCs Comprehensive cancer profiling: CTCs and ctDNA Banking the remnant plasma and slides for future analysisRead more

day: Day Two

10.45 | 7.45 – Integrating Liquid Biopsy as Part of a Clinical Development Strategy 10:45 am

Identifying opportunities in targeted therapeutic development where liquid biopsies work to compliment efficacy demonstration and perceived safety profile of a therapeutic in a target population Which challenges have been identified and been successfully overcome conducting trials incorporating liquid profiling assays? The future of liquid biopsies: Complementing or replacing the tissue as the ‘gold standard’Read more

day: Day One